Table 1.

Clinical description of schizophrenia patients (n=28)

	Mean	S.D.	Range
Age (years)	58.3	9.8	45–76
Duration of illness (years)	23.6	12.5	3–51
Antipsychotic dose (mg CPZE)a	328	369	0–1080
Duration of antipsychotic use (years)b	4.2	7.1	0.07–24.2
Anticholinergic dose	1.7	2.7	0–10
SAPSc score	5.5	4.2	0–16
SANSd score	8.7	4.5	1–18
Adjusted QWBe score	.57	.11	0.42–0.81
MMSEf score	26.0	3.0	17–30
BPRSg score	32.3	8.8	21–62
AIMSh score	7.3	4.3	1–19
Simpson–Angus EPSi score	21.3	6.1	12–35
Hamilton Depression Rating Scale score	9.6	4.8	3–24

^amg chlorpromazine equivalencies.

^bFor patients taking antipsychotics only.

^cScale for the Assessment of Positive Symptoms (range=0–20).

^dScale for the Assessment of Negative Symptoms (range=0–25).

^eQuality of Well Being (0=dead, 1.0=optimal health).

^fMini-Mental State Examination (range=0–30).

^gBrief Psychiatric Rating Scale (Overall and Gorham, 1962).

^hAbnormal Involuntary Movement Scale (Guy, 1976).

ⁱSimpson–Angus Extra Pyramidal Symptom Scale (Simpson and Angus, 1970).